Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour.
Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H, Jebsen NL, van de Sande M, Jones RL, Haglund F, Timmermans I, Safwat A, Bjerkehagen B, Boye K. Georgiesh T, et al. Among authors: napolitano a. Br J Cancer. 2022 Nov;127(10):1793-1798. doi: 10.1038/s41416-022-01959-4. Epub 2022 Aug 27. Br J Cancer. 2022. PMID: 36030294 Free PMC article.
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib.
Vincenzi B, Nannini M, Badalamenti G, Grignani G, Fumagalli E, Gasperoni S, D'Ambrosio L, Incorvaia L, Stellato M, Spalato Ceruso M, Napolitano A, Valeri S, Santini D, Tonini G, Casali PG, Dei Tos AP, Pantaleo MA. Vincenzi B, et al. Among authors: napolitano a. Ther Adv Med Oncol. 2018 Aug 29;10:1758835918794623. doi: 10.1177/1758835918794623. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30181783 Free PMC article.
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
Vincenzi B, Napolitano A, Fiocco M, Mir O, Rutkowski P, Blay JY, Reichardt P, Joensuu H, Fumagalli E, Gennatas S, Hindi N, Nannini M, Spalato Ceruso M, Italiano A, Grignani G, Brunello A, Gasperoni S, De Pas T, Badalamenti G, Pantaleo MA, van Houdt WJ, IJzerman NS, Steeghs N, Gelderblom H, Desar IME, Falkenhorst J, Silletta M, Sbaraglia M, Tonini G, Martin-Broto J, Hohenberger P, Le Cesne A, Jones RL, Dei Tos AP, Gronchi A, Bauer S, Casali PG. Vincenzi B, et al. Among authors: napolitano a. Clin Cancer Res. 2022 Apr 14;28(8):1672-1679. doi: 10.1158/1078-0432.CCR-21-1665. Clin Cancer Res. 2022. PMID: 34615721 Free PMC article.
Management of Vascular Sarcoma.
Subramaniam A, Giani C, Napolitano A, Ravi V, Frezza AM, Jones RL. Subramaniam A, et al. Among authors: napolitano a. Surg Oncol Clin N Am. 2022 Jul;31(3):485-510. doi: 10.1016/j.soc.2022.03.014. Surg Oncol Clin N Am. 2022. PMID: 35715146 Review.
Real-world evidence for ultra rare cancers.
Mavroeidis L, Napolitano A, Huang P, Jones RL. Mavroeidis L, et al. Among authors: napolitano a. Rare Tumors. 2024 Feb 15;16:20363613241234207. doi: 10.1177/20363613241234207. eCollection 2024. Rare Tumors. 2024. PMID: 38371426 Free PMC article. No abstract available.
715 results